Vasundhara Rasayans Ltd

Vasundhara Rasayans Ltd has announced the closure of its trading window from July 1, 2026, until 48 hours after the declaration of its financial results for the quarter ended June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, to prevent potential insider trading during the period leading up to and immediately following the announcement of financial performance. The company has submitted the relevant notice to the BSE.

The Board of Directors of 538634, in a meeting held on May 28, 2026, approved the appointment of Mr. Ravi Jain as an Additional Director, categorized as a Non-Executive Independent Director. The appointment is effective from May 28, 2026, for a term of 5 years, subject to the approval of shareholders at the upcoming general meeting. Mr. Jain brings over 10 years of experience in marketing and business development, with expertise in strategic planning, risk assessment, and governance. The company affirmed that Mr. Jain is not debarred from holding a directorship by SEBI or any other authority and is not related to any other director on the board.

Vasundhara Rasayans Limited's Board of Directors has approved a Memorandum of Understanding cum Loan-Lease Agreement with its holding company, PandJ Cretechem Private Limited. This agreement establishes a manufacturing arrangement for Active Pharmaceutical Ingredients (APIs) at the holding company's facility in Dahej, Gujarat. This move follows the termination of the company's previous manufacturing facility agreement in Mahad, Maharashtra, disclosed on March 30, 2026. The transaction was recommended by the Audit Committee and is considered an arm's length related party transaction. The listed entity will be responsible for obtaining the necessary licenses to manufacture APIs at the new facility, with no transfer of ownership or intellectual property involved.

Vasundhara Rasayans Limited's Board of Directors, in a meeting on May 28, 2026, reconstituted its Audit Committee, Nomination and Remuneration Committee (NRC), and Stakeholders Relationship Committee (SRC). This reconstitution was prompted by the retirement of Shri Pradeep Kumar Jain from these committees. The new compositions, effective May 29, 2026, include Mr. Manish Jain as Chairman for all three committees, along with other independent directors and executive directors for the SRC.

VASUNDHARA RASAYANS LIMITED announced the retirement of Shri. Pradeep Kumar Jain (DIN: 07553676) from his position as Non-Executive Independent Director. His retirement is effective from the close of business hours on May 28, 2026, following the completion of his second consecutive five-year term. The company has formally placed on record its appreciation for Shri. Jain's valuable contributions during his tenure on the Board. This intimation is in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The Board of Directors of 538634, in a meeting held on May 28, 2026, approved and took on record the Audited Standalone Financial Results for the fourth quarter and financial year ended March 31, 2026. The company's statutory auditors issued an unmodified opinion on these financial results. Additionally, the Board appointed Mr. Ravi Jain as an Additional Non-executive Independent Director and noted the retirement of Mr. Pradeep Kumar Jain from the same position. Key committees, including the Audit, Nomination and Remuneration, and Stakeholders Relationship Committees, were reconstituted with Mr. Manish Jain as chairperson. The Board also approved a Memorandum of Understanding cum Loan-Lease Agreement with PandJ Cretechem Private Limited (the Holding Company) for Active Pharmaceutical Ingredients (APIs) manufacturing.

The Board of Directors of 538634, at their meeting on May 28, 2026, approved the Audited Standalone Financial Results for the fourth quarter and financial year ended March 31, 2026, with an unmodified opinion. The Board appointed Mr. Ravi Jain as an Additional Non-Executive Independent Director and noted the retirement of Mr. Pradeep Kumar Jain. Furthermore, the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee were reconstituted, with Mr. Manish Jain appointed as chairperson for all three. A Memorandum of Understanding cum Loan-Lease Agreement with PandJ Cretechem Private Limited (Holding Company) for Active Pharmaceutical Ingredients (APIs) manufacturing at Dahej, Gujarat, was also approved.

Vasundhara Rasayans Ltd has scheduled a Board of Directors meeting on May 28, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The trading window for dealing in the company's equity shares is closed for designated persons until 48 hours after the declaration of the financial results.

Vasundhara Rasayans Limited has announced the closure of the trading window for dealing in the company's shares. The closure will be in effect from 1st April, 2026 till 48 hours after the declaration of financial results for the quarter and financial year ended 31 March, 2026. The decision is in accordance with the SEBI (Prohibition of Insider Trading) Regulations. The intimation of closure of the trading window was submitted to BSE on 31st March, 2026.

Vasundhara Rasayans Ltd. has received a communication from Keva Fragrances Private Limited, extending the effective date of termination under the Leave and License Agreement for their manufacturing facility. The termination date has been extended from March 31, 2026, to April 30, 2026. The company will continue to operate from the premises till April 30, 2026, and is in the process of identifying suitable alternate arrangements for its business operations thereafter.